| Joseph Tirone Alexander, MD | |
|
49 Spring St, 1st Floor, Scarborough, ME 04074-8926 | |
| (207) 885-0011 | |
| (207) 885-5851 |
| Full Name | Joseph Tirone Alexander |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 39 Years |
| Location | 49 Spring St, Scarborough, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457331035 | NPI | - | NPPES |
| 236810099 | Medicaid | ME | |
| 30207066 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD17332 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maine Medical Partners | 9335043967 | 789 |
| Mainehealth | 7517860588 | 2067 |
News Archive
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases.
Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the U.S. Food and Drug Administration (FDA) cleared the Company's 510K application for the MammoSite((R)) ML radiation therapy system.
Despite steadily improving methods for its diagnosis and treatment, cancer still represents one of the most frequent causes of death in humans. What is less well known is that this also holds true for pets such as dogs.
› Verified 3 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144090 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000191 |
News Archive
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases.
Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the U.S. Food and Drug Administration (FDA) cleared the Company's 510K application for the MammoSite((R)) ML radiation therapy system.
Despite steadily improving methods for its diagnosis and treatment, cancer still represents one of the most frequent causes of death in humans. What is less well known is that this also holds true for pets such as dogs.
› Verified 3 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases.
Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the U.S. Food and Drug Administration (FDA) cleared the Company's 510K application for the MammoSite((R)) ML radiation therapy system.
Despite steadily improving methods for its diagnosis and treatment, cancer still represents one of the most frequent causes of death in humans. What is less well known is that this also holds true for pets such as dogs.
› Verified 3 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992719272 PECOS PAC ID: 9335043967 Enrollment ID: O20050901000035 |
News Archive
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases.
Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the U.S. Food and Drug Administration (FDA) cleared the Company's 510K application for the MammoSite((R)) ML radiation therapy system.
Despite steadily improving methods for its diagnosis and treatment, cancer still represents one of the most frequent causes of death in humans. What is less well known is that this also holds true for pets such as dogs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Tirone Alexander, MD 301 Us Route 1, Building C, Scarborough, ME 04074-7609 Ph: (207) 396-8600 | Joseph Tirone Alexander, MD 49 Spring St, 1st Floor, Scarborough, ME 04074-8926 Ph: (207) 885-0011 |
News Archive
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases.
Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the U.S. Food and Drug Administration (FDA) cleared the Company's 510K application for the MammoSite((R)) ML radiation therapy system.
Despite steadily improving methods for its diagnosis and treatment, cancer still represents one of the most frequent causes of death in humans. What is less well known is that this also holds true for pets such as dogs.
› Verified 3 days ago
James Wilson, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-0011 Fax: 207-883-2586 | |
William F. D'angelo, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 | |
Dr. Robert D Ecker, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-0011 Fax: 207-885-5851 | |
Dr. Matthew R Sanborn, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring Street, Scarborough, ME 04074 Phone: 207-885-0011 Fax: 207-885-5851 | |
Dr. Susan Catherine Williams, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 92 Campus Dr Ste A, Scarborough, ME 04074 Phone: 207-885-0011 | |
Jeffrey E Florman, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 | |
Dr. George Roth, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 |